Lung Cancer Awareness Month: Optellum’s AI platform demonstrates a vital role in efficient diagnosis to improve lung cancer survival rates

Lung cancer is the leading cause of cancer deaths worldwide, with approximately 1.8 million people dying from lung cancer each year. The majority of patients are diagnosed after symptoms have…

Continue ReadingLung Cancer Awareness Month: Optellum’s AI platform demonstrates a vital role in efficient diagnosis to improve lung cancer survival rates

Optellum, AI Lung Cancer Diagnosis Innovator,
Secures $14M Series A Funding to Accelerate Expansion

Lead investor Mercia, alongside Intuitive Ventures and Black Opal, invests inOptellum’s pioneering AI-powered lung-health technology Oxford, 27 September 2022, 8am: Optellum, an Oxford-based medtech company that provides a breakthrough AI…

Continue ReadingOptellum, AI Lung Cancer Diagnosis Innovator,
Secures $14M Series A Funding to Accelerate Expansion
Read more about the article How Optellum is working to change the survival rates for lung cancer with an innovative AI platform
World lung cancer day badge

How Optellum is working to change the survival rates for lung cancer with an innovative AI platform

  • Post category:News and PR

Optellum was founded with the vision of providing clinical decision support software that could help lung disease patients be diagnosed and treated with curative intent at the earliest possible stage.…

Continue ReadingHow Optellum is working to change the survival rates for lung cancer with an innovative AI platform

PRESS RELEASE: CMS assigns new technology payment classification for Optellum’s Lung Cancer Prediction score

This payment assignment to a newly available Healthcare Common Procedure Coding System (HCPCS) code constitutes an important step towards reimbursing providers for the use of Optellum’s transformative technology with Medicare…

Continue ReadingPRESS RELEASE: CMS assigns new technology payment classification for Optellum’s Lung Cancer Prediction score

Optellum’s UK regulatory certification bolstered by UKCA marking for its early lung cancer diagnosis AI technology

After gaining CE certification for its software Virtual Nodule Clinic, Optellum has attained UKCA certification under the UK’s Medical Devices Regulations. Optellum, an Oxford-based medtech company, provides breakthrough AI technologies…

Continue ReadingOptellum’s UK regulatory certification bolstered by UKCA marking for its early lung cancer diagnosis AI technology

PRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation. Oxford, UK – 30 March 2022:…

Continue ReadingPRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

Optellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report

Optellum is referenced within the report with recommendations on how AI will be implemented and physicians trained in new technologies across the NHS Optellum has been named as one of…

Continue ReadingOptellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

Oxford, UK/Chalfont St Giles 26 November 2021 13:00 GMT - GE Healthcare and Optellum today announced that they have signed a letter of intent to collaborate to advance precision diagnosis…

Continue ReadingPRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

PRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA

Fast-growing lung-health AI startup strengthens executive team with business leader experienced in medical devices for lung cancer diagnosis. Jason Pesterfield was previously CEO at Veran Medical Technologies, growing it through…

Continue ReadingPRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA

PRESS RELEASE: Optellum Announces Strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson, Applying AI to Transform Early Lung Cancer Treatment

Rapidly growing lung health startup aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software. OXFORD, UK / HOUSTON, USA – August 18, 2021: Optellum,…

Continue ReadingPRESS RELEASE: Optellum Announces Strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson, Applying AI to Transform Early Lung Cancer Treatment

AI software could help clinicians diagnose lung cancer earlier and reduce waiting lists for patients

A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding. This is a…

Continue ReadingAI software could help clinicians diagnose lung cancer earlier and reduce waiting lists for patients